Olaparib plus abiraterone could be a new first-line treatment option for mCRPC | Fred Saad from olaparib prostate cancer Watch Video
Preview(s):
Gallery
Gallery
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 3 minutes 41 seconds 👁 View: 193 times
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)